Proposition - PharmXpert Academy

The Korean Pharmaceutical Company List 361
13. DONG-A PHARM. CO., LTD.
1. Company Information
Company
DONG-A PHARM. CO., LTD.
Representative KIM WON BAE E-mail wbkim@donga.co.kr
Representative
Phone No.
Hompage
Address
Research
Institute Address
Year of
Establishment
The Number of
Employees (06‘)
02)920-8000
wbkim@donga.co.kr
http://www.donga.co.kr
Representative
Fax No.
02)928-4468
Sanggal-dong 47-5, Giheung-gu, Yongin-si, Gyeonggi-do
1932 Sales (‘06) 842.9 Million $
Total
The Number of
2,074 Researcher (‘06) 171
Total
Contact Person LIM JAE WAN Contact Phone 02)920-8885
Contact E-mail jaewan@donga.co.kr Contact Fax 02)925-4026
Introduction of Company
In 1988, Dong-A was the first of its kind to establish a research laboratory(KGLP R&D center)
in Korea and, with goals of in the global market, has been a leader of new drug research ever
since.
Our research laboratory has successful in developing 4 major biopharmaceutical products(EPO,
G-CSF, h-GH and Interferon-α) and exporting new material synthesis technology. Currently the
three main research departments are woking towards the development of innovative new drug,
biopharmaceuticals and new fomulation products.
New drug discovery department has concentrated not only on the development of
Stillen(treatment of peptic ulcer), Zydena(treatment of erectile dysfunction) but also on the
develoment of `Quality of life' drug such as treatment for osteoporosis, obesity, allergy, rhematic
arthritis, and eretile dysfuction.
For biopharmaceutical department, concentrated investment in the fields of life science such as
recombinant protein, protein delivery, tissue engineering and gene therapy to create highly valued
biophamaceuticals. Currently, we are closed to developing biopharmaceutical products including
HIV DNA vaccine, long acting growth hormones, and artificial skin. New formulation research
Department is focusing on expanding the range of over-the-counter(OTC) products, and
developing new formulations to improve drug profiles, which will eventually increase the benefit
for the consumer.